Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Onco-Nutrition and Supplements Market by Cancer Type (Blood Cancer,Liver Cancer,Pancreatic Cancer,Breast Cancer,Head and Neck Cancer,Lung Cancer,Stomach and Gastrointestinal Cancer,Others), by End User (Hospitals,Specialty Clinics,Homecare Centers,Others): Global Report opportunity Analysis and Industry Forecast, 2023-2033

A10905

Pages: NA

Charts: NA

Tables: NA

Onco-Nutrition and Supplements Market Outlook - 2027

The nutritional status of patient suffering with cancer is affected negatively due to cancer itself or indirectly via tumor-induced metabolic changes also referred to as cancer cachexia or cancer-induced malnutrition. Most of the oncology treatments cause side effects that reduce appetite and food intake. Some of these adverse effects persist for long-term. Hence, proper nutrition during oncology therapeutics is crucial. Appropriate nutrition is clinical for maintaining proper health during and post cancer treatment. Research and studies have also found evidences regarding the proper nutrition that helps in boosting the immunity and aids in prevention of cancer and simultaneously increases the effectiveness of cancer therapeutics. Oncology patients understand the importance of essential nutrition as it has enormous effect on the treatment. Consuming a variety of foods containing nutritional elements and well-balanced meals assist them in staying stronger during the course of treatment.  It also aids in maintaining proper body weight, preserving optimal levels of energy and strength, reduces the risk and complications related to infection and helps in rapid recovery. High protein diets are recommended for patients suffering from cancer.

COVID – 19 scenario analysis:

  • Due to the COVID – 19  outbreak, majority of healthcare, pharmaceutical and biotechnology organizations have concentrated on diagnostics kits, safety wearables (PPE kits, face shields, masks) and treatment therapies and medication against Novel coronavirus
  • R&D labs are also focusing on finding a breakthrough vaccine against Novel coronavirus
  • In addition, the medical professionals are engaged in providing COVID-19 related services, as a result, other healthcare segments  have to face negligence
  • As there is strain on healthcare providers and the hospitals are flooding with patients suffering with SARS-CoV-2 and the intake capacity of hospitals already at its peak
  • Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to oncology nutrition has been reduced and this segment have to face negligence subsequently causing negative impact on onco-nutrition and supplements market
  • Some research from China, has also stated that cancer patients are at higher risk as they’re vulnerable against SARS-CoV-2 and have higher chances of getting infected with the virus

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The onco-nutrition and supplements market is expected to witness significant growth in coming years due to factors such as increasing prevalence of cancer creating large patient pools, shifting focus to enteral from parenteral nutrition, rising demand for appropriate nutritional intake in cancer patients, rising incidences of patients suffering with malnutrition due to cancer itself as well as cancer therapies, and increasing clinical research in the field of nutritional interventions in disease management. The other factors like the increasing demand for nutritional products, availability of nutritional consumables and rising need to meet oncology patient’s daily nutritional intake. Furthermore, the rising requirement related to enteral nutrition for patients suffering with head and neck cancer would facilitate the market growth. Increasing number of cancer patients surge the uptake of tube feeding formulas, which helps in proper nutritional intake in extreme medical conditions due to cancer. Hence, the rise in the enteral nutrition will stimulate the growth of onco-nutrition and supplements market.

On the contrary, the unfavorable reimbursement policies related with the tube feeding systems and negligence of importance of nutrition in cancer therapeutics and recovery are some factors anticipated to impede the growth of the onco-nutrition and supplements market to a certain extent.

Having said that, drastic rise in demand for meeting nutritional intake in the homecare settings coupled with high usage of nutritional supplements will amplify the market growth and create growth and market expansion opportunities for the onco-nutrition and supplements market. Statistics further suggest that approximately 1.5 million people in the U.S. are diagnosed with some form of cancer every year which facilitates the higher consumption of nutritional supplements including herbs, vitamins, and extracts that aid in strengthening the immunity and provide relief from adverse effects of radiation and chemotherapy.

Dietary factors and changing lifestyle to propel the market

Dietary factors play a pivotal role in the acquiring and treatment of cancer. Unhealthy diet coupled with unhealthy lifestyle increase chances of getting affected with cancer. Obesity and diet can be directly associated with almost 30% to 35% of fatalities caused due to cancer, while lethargic lifestyle and physical inactivity results in 7% cancer risk. Almost 85% of all cancer cases around the world are linked with changing diet and lifestyle. Food and nutritional intake significantly contributes to cancer development on one hand and cancer prevention and effective management on the other. Clinical research outcomes are constantly being upgraded by using Oncology Nutrition in integration with therapeutics as a holistic approach to oncology. Thus the change in dietary factors coupled with lethargic lifestyle would fuel the market growth. Also, the World Health Organization (WHO) in their report, mentioned the rate of obesity has tripled since 1975 worldwide. Year 2016 saw over 1.9 billion adults belonging to age group 18 years or above were overweight and out of them, over one third of people were obese. As a result, problems arising due to obesity would create demand for onco-nutrition and supplements thereby propelling the market growth.

Rising prevalence of cancer to boost the growth

According to the Cancer Research UK, around 17 million cancer cases were registered in 2018, out of which 56% of the cases were fatal. There are many key factors that may affect the success rate of chemo and radiation therapy and a person's survival rate such as age, overall health and cancer stage. As per a research report by the World Health Organization (WHO), in low- and middle-income countries, around 70% of deaths occurs due to cancer. Increase in smoking habits, genetic mutation, alcohol and hormones consumption, urban air pollution are the frequent reasons for the increasing number of cancer patients in the world. Rising number of cancer across the globe is proving to be significant for boosting the growth of onco-nutrition and supplements market.


Key benefits of the report:

  • This study presents the analytical depiction of the global onco-nutrition and supplements industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global onco-nutrition and supplements market share.
  • The current market is quantitatively analyzed to highlight the global onco-nutrition and supplements market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global onco-nutrition and supplements market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Onco-nutrition and supplements Market research report:

  • What are the leading market players active in the onco-nutrition and supplements market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Key Market Segments

  • By Cancer Type
    • Blood Cancer
    • Liver Cancer
    • Pancreatic Cancer
    • Breast Cancer
    • Head and Neck Cancer
    • Lung Cancer
    • Stomach and Gastrointestinal Cancer
    • Others
  • By End User
    • Hospitals
    • Specialty Clinics
    • Homecare Centers
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • Uk
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA


Key Market Players

  • B. Braun Melsungen AG
  • Mead Johnson Nutrition Company
  • Meiji Holdings.
  • Abbott Laboratories
  • Danone
  • Nestle S.A
  • Global Health Products
  • Victus
  • Fresenius Kabi AG
  • Hormel Foods


Other Players

  • Pfizer Inc.
  • Grifols S.A.
  • Baxter International, Inc
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: ONCO-NUTRITION AND SUPPLEMENTS MARKET, BY CANCER TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Cancer Type

    • 4.2. Blood Cancer

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Liver Cancer

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Pancreatic Cancer

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Breast Cancer

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Head And Neck Cancer

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. Lung Cancer

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

    • 4.8. Stomach And Gastrointestinal Cancer

      • 4.8.1. Key Market Trends, Growth Factors and Opportunities

      • 4.8.2. Market Size and Forecast, By Region

      • 4.8.3. Market Share Analysis, By Country

    • 4.9. Others

      • 4.9.1. Key Market Trends, Growth Factors and Opportunities

      • 4.9.2. Market Size and Forecast, By Region

      • 4.9.3. Market Share Analysis, By Country

  • CHAPTER 5: ONCO-NUTRITION AND SUPPLEMENTS MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospitals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Specialty Clinics

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Homecare Centers

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Others

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: ONCO-NUTRITION AND SUPPLEMENTS MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Cancer Type

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Onco-nutrition And Supplements Market

        • 6.2.5.1. Market Size and Forecast, By Cancer Type
        • 6.2.5.2. Market Size and Forecast, By End User
      • 6.2.6. Canada Onco-nutrition And Supplements Market

        • 6.2.6.1. Market Size and Forecast, By Cancer Type
        • 6.2.6.2. Market Size and Forecast, By End User
      • 6.2.7. Mexico Onco-nutrition And Supplements Market

        • 6.2.7.1. Market Size and Forecast, By Cancer Type
        • 6.2.7.2. Market Size and Forecast, By End User
    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Cancer Type

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Onco-nutrition And Supplements Market

        • 6.3.5.1. Market Size and Forecast, By Cancer Type
        • 6.3.5.2. Market Size and Forecast, By End User
      • 6.3.6. Germany Onco-nutrition And Supplements Market

        • 6.3.6.1. Market Size and Forecast, By Cancer Type
        • 6.3.6.2. Market Size and Forecast, By End User
      • 6.3.7. Italy Onco-nutrition And Supplements Market

        • 6.3.7.1. Market Size and Forecast, By Cancer Type
        • 6.3.7.2. Market Size and Forecast, By End User
      • 6.3.8. Spain Onco-nutrition And Supplements Market

        • 6.3.8.1. Market Size and Forecast, By Cancer Type
        • 6.3.8.2. Market Size and Forecast, By End User
      • 6.3.9. UK Onco-nutrition And Supplements Market

        • 6.3.9.1. Market Size and Forecast, By Cancer Type
        • 6.3.9.2. Market Size and Forecast, By End User
      • 6.3.10. Russia Onco-nutrition And Supplements Market

        • 6.3.10.1. Market Size and Forecast, By Cancer Type
        • 6.3.10.2. Market Size and Forecast, By End User
      • 6.3.11. Rest Of Europe Onco-nutrition And Supplements Market

        • 6.3.11.1. Market Size and Forecast, By Cancer Type
        • 6.3.11.2. Market Size and Forecast, By End User
    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Cancer Type

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Onco-nutrition And Supplements Market

        • 6.4.5.1. Market Size and Forecast, By Cancer Type
        • 6.4.5.2. Market Size and Forecast, By End User
      • 6.4.6. Japan Onco-nutrition And Supplements Market

        • 6.4.6.1. Market Size and Forecast, By Cancer Type
        • 6.4.6.2. Market Size and Forecast, By End User
      • 6.4.7. India Onco-nutrition And Supplements Market

        • 6.4.7.1. Market Size and Forecast, By Cancer Type
        • 6.4.7.2. Market Size and Forecast, By End User
      • 6.4.8. South Korea Onco-nutrition And Supplements Market

        • 6.4.8.1. Market Size and Forecast, By Cancer Type
        • 6.4.8.2. Market Size and Forecast, By End User
      • 6.4.9. Australia Onco-nutrition And Supplements Market

        • 6.4.9.1. Market Size and Forecast, By Cancer Type
        • 6.4.9.2. Market Size and Forecast, By End User
      • 6.4.10. Thailand Onco-nutrition And Supplements Market

        • 6.4.10.1. Market Size and Forecast, By Cancer Type
        • 6.4.10.2. Market Size and Forecast, By End User
      • 6.4.11. Malaysia Onco-nutrition And Supplements Market

        • 6.4.11.1. Market Size and Forecast, By Cancer Type
        • 6.4.11.2. Market Size and Forecast, By End User
      • 6.4.12. Indonesia Onco-nutrition And Supplements Market

        • 6.4.12.1. Market Size and Forecast, By Cancer Type
        • 6.4.12.2. Market Size and Forecast, By End User
      • 6.4.13. Rest of Asia Pacific Onco-nutrition And Supplements Market

        • 6.4.13.1. Market Size and Forecast, By Cancer Type
        • 6.4.13.2. Market Size and Forecast, By End User
    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Cancer Type

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Onco-nutrition And Supplements Market

        • 6.5.5.1. Market Size and Forecast, By Cancer Type
        • 6.5.5.2. Market Size and Forecast, By End User
      • 6.5.6. South Africa Onco-nutrition And Supplements Market

        • 6.5.6.1. Market Size and Forecast, By Cancer Type
        • 6.5.6.2. Market Size and Forecast, By End User
      • 6.5.7. Saudi Arabia Onco-nutrition And Supplements Market

        • 6.5.7.1. Market Size and Forecast, By Cancer Type
        • 6.5.7.2. Market Size and Forecast, By End User
      • 6.5.8. UAE Onco-nutrition And Supplements Market

        • 6.5.8.1. Market Size and Forecast, By Cancer Type
        • 6.5.8.2. Market Size and Forecast, By End User
      • 6.5.9. Argentina Onco-nutrition And Supplements Market

        • 6.5.9.1. Market Size and Forecast, By Cancer Type
        • 6.5.9.2. Market Size and Forecast, By End User
      • 6.5.10. Rest of LAMEA Onco-nutrition And Supplements Market

        • 6.5.10.1. Market Size and Forecast, By Cancer Type
        • 6.5.10.2. Market Size and Forecast, By End User
  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Abbott Laboratories

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Nestle S.A

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Fresenius Kabi AG

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Danone

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. B. Braun Melsungen AG

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Global Health Products

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Hormel Foods

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Mead Johnson Nutrition Company

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Victus

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Meiji Holdings.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR BLOOD CANCER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR LIVER CANCER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR PANCREATIC CANCER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR BREAST CANCER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR HEAD AND NECK CANCER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR LUNG CANCER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR STOMACH AND GASTROINTESTINAL CANCER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR SPECIALTY CLINICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR HOMECARE CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA ONCO-NUTRITION AND SUPPLEMENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 19. U.S. ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 20. U.S. ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 21. CANADA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 22. CANADA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 23. MEXICO ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 24. MEXICO ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 25. EUROPE ONCO-NUTRITION AND SUPPLEMENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 26. EUROPE ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 27. EUROPE ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 28. FRANCE ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 29. FRANCE ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 30. GERMANY ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 31. GERMANY ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 32. ITALY ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 33. ITALY ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 34. SPAIN ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 35. SPAIN ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 36. UK ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 37. UK ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 38. RUSSIA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 39. RUSSIA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 40. REST OF EUROPE ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 41. REST OF EUROPE ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 42. ASIA-PACIFIC ONCO-NUTRITION AND SUPPLEMENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 43. ASIA-PACIFIC ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 44. ASIA-PACIFIC ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 45. CHINA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 46. CHINA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 47. JAPAN ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 48. JAPAN ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 49. INDIA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 50. INDIA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 51. SOUTH KOREA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 52. SOUTH KOREA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 53. AUSTRALIA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 54. AUSTRALIA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 55. THAILAND ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 56. THAILAND ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 57. MALAYSIA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 58. MALAYSIA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 59. INDONESIA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 60. INDONESIA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 61. REST OF ASIA PACIFIC ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 62. REST OF ASIA PACIFIC ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 63. LAMEA ONCO-NUTRITION AND SUPPLEMENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 64. LAMEA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 65. LAMEA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 66. BRAZIL ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 67. BRAZIL ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH AFRICA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 69. SOUTH AFRICA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 70. SAUDI ARABIA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 71. SAUDI ARABIA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 72. UAE ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 73. UAE ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 74. ARGENTINA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 75. ARGENTINA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 76. REST OF LAMEA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2025-2033 ($MILLION)
  • TABLE 77. REST OF LAMEA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 78. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 79. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 80. ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 81. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 82. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 83. NESTLE S.A: KEY EXECUTIVES
  • TABLE 84. NESTLE S.A: COMPANY SNAPSHOT
  • TABLE 85. NESTLE S.A: OPERATING SEGMENTS
  • TABLE 86. NESTLE S.A: PRODUCT PORTFOLIO
  • TABLE 87. NESTLE S.A: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 88. FRESENIUS KABI AG: KEY EXECUTIVES
  • TABLE 89. FRESENIUS KABI AG: COMPANY SNAPSHOT
  • TABLE 90. FRESENIUS KABI AG: OPERATING SEGMENTS
  • TABLE 91. FRESENIUS KABI AG: PRODUCT PORTFOLIO
  • TABLE 92. FRESENIUS KABI AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 93. DANONE: KEY EXECUTIVES
  • TABLE 94. DANONE: COMPANY SNAPSHOT
  • TABLE 95. DANONE: OPERATING SEGMENTS
  • TABLE 96. DANONE: PRODUCT PORTFOLIO
  • TABLE 97. DANONE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 98. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
  • TABLE 99. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 100. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 101. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 102. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 103. GLOBAL HEALTH PRODUCTS: KEY EXECUTIVES
  • TABLE 104. GLOBAL HEALTH PRODUCTS: COMPANY SNAPSHOT
  • TABLE 105. GLOBAL HEALTH PRODUCTS: OPERATING SEGMENTS
  • TABLE 106. GLOBAL HEALTH PRODUCTS: PRODUCT PORTFOLIO
  • TABLE 107. GLOBAL HEALTH PRODUCTS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108. HORMEL FOODS: KEY EXECUTIVES
  • TABLE 109. HORMEL FOODS: COMPANY SNAPSHOT
  • TABLE 110. HORMEL FOODS: OPERATING SEGMENTS
  • TABLE 111. HORMEL FOODS: PRODUCT PORTFOLIO
  • TABLE 112. HORMEL FOODS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. MEAD JOHNSON NUTRITION COMPANY: KEY EXECUTIVES
  • TABLE 114. MEAD JOHNSON NUTRITION COMPANY: COMPANY SNAPSHOT
  • TABLE 115. MEAD JOHNSON NUTRITION COMPANY: OPERATING SEGMENTS
  • TABLE 116. MEAD JOHNSON NUTRITION COMPANY: PRODUCT PORTFOLIO
  • TABLE 117. MEAD JOHNSON NUTRITION COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. VICTUS: KEY EXECUTIVES
  • TABLE 119. VICTUS: COMPANY SNAPSHOT
  • TABLE 120. VICTUS: OPERATING SEGMENTS
  • TABLE 121. VICTUS: PRODUCT PORTFOLIO
  • TABLE 122. VICTUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 123. MEIJI HOLDINGS.: KEY EXECUTIVES
  • TABLE 124. MEIJI HOLDINGS.: COMPANY SNAPSHOT
  • TABLE 125. MEIJI HOLDINGS.: OPERATING SEGMENTS
  • TABLE 126. MEIJI HOLDINGS.: PRODUCT PORTFOLIO
  • TABLE 127. MEIJI HOLDINGS.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET
  • FIGURE 3. SEGMENTATION ONCO-NUTRITION AND SUPPLEMENTS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN ONCO-NUTRITION AND SUPPLEMENTS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALONCO-NUTRITION AND SUPPLEMENTS MARKET
  • FIGURE 11. ONCO-NUTRITION AND SUPPLEMENTS MARKET SEGMENTATION, BY BY CANCER TYPE
  • FIGURE 12. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR BLOOD CANCER, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR LIVER CANCER, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR PANCREATIC CANCER, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR BREAST CANCER, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR HEAD AND NECK CANCER, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR LUNG CANCER, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR STOMACH AND GASTROINTESTINAL CANCER, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. ONCO-NUTRITION AND SUPPLEMENTS MARKET SEGMENTATION, BY BY END USER
  • FIGURE 21. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR HOMECARE CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 26. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 27. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 28. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 29. COMPETITIVE DASHBOARD
  • FIGURE 30. COMPETITIVE HEATMAP: ONCO-NUTRITION AND SUPPLEMENTS MARKET
  • FIGURE 31. TOP PLAYER POSITIONING, 2024
  • FIGURE 32. ABBOTT LABORATORIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. NESTLE S.A: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. NESTLE S.A: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. NESTLE S.A: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. FRESENIUS KABI AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. FRESENIUS KABI AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. FRESENIUS KABI AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. DANONE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. DANONE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. DANONE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. B. BRAUN MELSUNGEN AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. GLOBAL HEALTH PRODUCTS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. GLOBAL HEALTH PRODUCTS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. GLOBAL HEALTH PRODUCTS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. HORMEL FOODS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. HORMEL FOODS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. HORMEL FOODS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. MEAD JOHNSON NUTRITION COMPANY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. MEAD JOHNSON NUTRITION COMPANY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. MEAD JOHNSON NUTRITION COMPANY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. VICTUS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. VICTUS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. VICTUS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 59. MEIJI HOLDINGS.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 60. MEIJI HOLDINGS.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 61. MEIJI HOLDINGS.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Onco-Nutrition and Supplements Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue